Yoshitaka Imanishi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
*Corresponding author: Mailing address: Virology and Bacteriology Division, Nara Prefectural Institute for Hygiene and Environment, 57-6 Ohmori-cho, Nara city, Nara 630-8131, Japan. Tel: +81-742-20-2887, Fax: +81-742-27-0634, E-mail: y.kitahori@ihe.pref.nara.jp Several viral strains have been associated with the development of acute gastroenteritis in(More)
*Corresponding author: Mailing address: Virology and Bacteriology Division, Nara Prefectural Institute for Hygiene and Environment, 57-6 Ohmori-cho, Nara city, Nara 630-8131, Japan. Tel: +81-742-20-2887, Fax: +81-742-27-0634, E-mail: y.kitahori @ihe.pref.nara.jp Norovirus (NoV) is usually prevalent in the early winter season and causes symptoms of acute(More)
*Corresponding author: Mailing address: Virology and Bacteriology Division, Nara Prefectural Institute for Hygiene and Environment, Ohmori-cho, Nara City, Nara 630-8131, Japan. Tel: +81-742-20-2887, Fax: +81-742-27-0634, E-mail: y.inoue @ihe.pref.nara.jp Rotavirus is the most common cause of severe diarrhea among children. There are seven groups of this(More)
Amantadine is the first anti-influenza drug licensed in Japan. The drug inhibits virus replication during the early stage of infection by blocking the ion channel formed by the M2 protein. A single substitution at 1 of 4 residues of M2 protein (positions 26, 27, 30 and 31) has been shown to confer resistance to adamantane. In 2005, Bright and colleagues’(More)
  • 1